Outcome indicators*
| Quality indicator | Overall (N=3041) | Stable CAD (N=542) | ACS (N=2499) | ||||
|---|---|---|---|---|---|---|---|
| n (%) | Hospital range (%) | n (%) | Hospital range (%) | n (%) | Hospital range (%) | p Value† | |
| Mortality | |||||||
| In-hospital | 62 (2.0%) | 0–6.2 | ≤5 | 0–28.6 | 58 (2.3%) | 0–5.4 | 0.018 |
| 30 days | 86 (2.8%) | 0–7.8 | 7 (1.3%) | 0–42.9 | 79 (3.2%) | 0–6.5 | 0.017 |
| 1 year | 162 (5.3%) | 2.0–11.4 | 14 (2.6%) | 0–42.9 | 148 (5.9%) | 2.2–10.2 | 0.002 |
| Emergency CABG | 35 (1.2%) | 0–4.8 | ≤5 | NA | 34 (1.4%) | 0–4.8 | 0.02 |
| Emergency repeat PCI | 35 (1.2%) | 0–4.5 | 0 | 0 | 35 (1.4%) | 0–4.9 | 0.006 |
| Renal failure requiring dialysis | 6 (0.2%) | 0–1.0 | ≤5 | NA | ≤5 | NA | 0.941 |
| Stroke or transient ischaemic attack | 15 (0.5%) | 0–1.4 | 0 | 0 | 15 (0.6%) | 0–1.5 | 0.071 |
| Myocardial infarction | 34 (1.1%) | 0–3.5 | ≤5 | NA | 33 (1.3%) | 0–3.6 | 0.023 |
| Intra-aortic balloon pump insertion | 99 (3.3%) | 0–10.1 | ≤5 | NA | 97 (3.9%) | 0–10.3 | <0.001 |
| Bleeding/access site complications | 48 (1.6%) | 0–6.1 | 7 (1.3%) | 0–14.3 | 41 (1.6%) | 0–5.8 | 0.554 |
| Vascular repair | 25 (0.8%) | 0–3.2 | ≤5 | NA | 23 (0.9%) | 0–4.1 | 0.198 |
| Blood transfusion | 29 (1.0%) | 0–3.2 | 0 | 0 | 29 (1.2%) | 0–3.3 | 0.012 |
| Thrombocytopaenia | 8 (0.3%) | 0–1.5 | 0 | 0 | 8 (0.3%) | 0–1.6 | 0.187 |
*Outcomes with less than or equal to five events are reported in the table as “≤5” because of privacy legislation to protect patient confidentiality.
ACS, acute coronary syndrome; CABG, coronary artery bypass grafting; CAD, coronary artery disease; PCI, percutaneous coronary intervention.